| 期刊論文1. | Marmot, M.(2005)。Social determinants of health inequalities。Lancet,365,1099-1104。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 2. | Hsu, C. C.、Lee, C. H.、Wahlqvist, M. L.(2012)。Poverty increases type 2 diabetes incidence and inequality of care despite universal health coverage。Diabetes Care,35,2286-2292。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 3. | Alter, D. A.、Iron, K.、Austin, P. C.、Naylor, C. D.(2004)。Socioeconomic Status, Service Patterns, and Perceptions of Care among Survivors of Acute Myocardial Infarction in Canada。JAMA,291,1100-1107。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 4. | Jakobsen, L.、Niemann, T.、Thorsgaard, N.(2004)。Dimensions of socioeconomic status and clinical outcome after primary percutaneous coronary intervention。Circ Cardiovasc Interv,5,641-648。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 5. | Shimony, A.、Zahger, D.、Ilia, R.、Shalev, A.、Cafri, C.(2010)。Impact of the community's socioeconomic status on characteristics and outcomes of patients undergoing percutaneous coronary intervention。Int J Cardiol,144,379-382。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 6. | Mehta, R. H.、O' Shea, J. C.、Stebbins, A. L.(2011)。Association of mortality with years of education in patients with ST-segment elevation myocardial infarction treated with fibrinolysis。J Am Coll Cardiol,57,138-146。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 7. | Stirbu, I.、Looman, C.、Nijhof, G. J.、Reulings, P. G.、Mackenbach, J. P.(2012)。Income inequalities in case death of ischaemic heart disease in the Netherlands: a national record-linked study。J Epidemiol Community Health,66,1159-1166。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 8. | Hardarson, T.、Gardarsdottir, M.、Gudmundsson, K. T.、Thorgeirsson, G.、Sigvaldason, H.、Sigfusson, N.(2001)。The relationship between educational level and mortality。The Reykjavik Study. J Intern Med,249,495-502。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 9. | Denvir, M. A.、Lee, A. J.、Rysdale, J.、Walker, A.、Eteiba, H.、Starkey, I. R.、Pell, J. P.(2006)。Influence of socioeconomic status on clinical outcomes and quality of life after percutaneous coronary intervention。Journal of Epidemiology & Community Health,60,1085-1088。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 10. | 洪尉欽(2008)。冠狀動脈心臟病及介入性治療。義大醫訊,4,26-30。 延伸查詢![new window](/gs32/images/newin.png) | 11. | Aggarwal, B.、Ellis, S. G.、Lincoff, A. M.(2013)。Cause of death within 30 days of percutaneous coronary intervention in an era of mandatory outcome reporting。J Am Coll Cardiol,62,409-15。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 12. | Shishehbor, M. H.、Goel, S. S.、Kapadia, S. R.(2008)。Longterm impact of drug-eluting stents versus bare-metal stents on all-cause mortality。J Am Coll Cardiol,52,1041-8。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 13. | Pandya, S. B.、Kim, Y. H.、Meyers, S. N.(2010)。Drug-eluting versus bare-metal stents in unprotected left main coronary artery stenosis a meta-analysis。JACC Cardiovasc Interv,3,602-11。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 14. | Epstein, A. J.、Polsky, D.、Yang, F.、Yang, L.、Groeneveld, P. W.(2011)。Coronary revascularization trends in the United States 2001-2008。JAMA,305,1769-76。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 15. | Puymirat, E.、Mangiacapra, F.、Peace, A.(2013)。Safety and effectiveness of drug-eluting stents versus baremetal stents in elderly patients with small coronary vessel disease。Arch Cardiovasc Dis,106,554-61。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 16. | 黃雪娥、陳科呈、殷偉賢、蔡維河、葉明陽(20100800)。塗藥心臟血管支架之醫療費用結構與成本效益分析--與傳統支架之比較。內科學誌,21(4),258-269。 延伸查詢![new window](/gs32/images/newin.png) | 17. | Mieres, J.、Fernandez-Pereira, C.、Risau, G.(2012)。One Year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)。Cardiovasc Revasc Med,13,265-271。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 18. | Loh, J. P.、Pendyala, L. K.、Kitabata, H.(2013)。A propensity score matched analysis to determine if secondgeneration drug-eluting stents outperform firstgeneration drug-eluting stents in a complex patient population。Int J Cardiol,170,43-48。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 19. | Kalesan, B.、Pilgrim, T.、Heinimann, K.(2012)。Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction。Eur Heart J,33,977-987。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 20. | Salomaa, V.、Niemela, M.、Miettinen, H.(2000)。Relationship of socioeconomic status to the incidence and prehospital, 28-day, and 1-year mortality rates of acute coronary events in the FINMONICA myocardial infarction register study。Circulation,101,1913-1918。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 21. | Alter, D. A.、Franklin, B.、Ko, D. T.(2013)。Socioeconomic status, functional recovery, and long-term mortality among patients surviving acute myocardial infarction。PLoS One,8,e65130。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 22. | Sandgren, T.、Sonesson, B.、Ahlgren, R.、Lanne, T.(1999)。The diameter of the common femoral artery in healthy human: influence of sex, age, and body size。J Vasc Surg,29,503-510。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 23. | Mikhail, G. W.(2006)。Coronary revascularisation in women。Heart,92 (Suppl 3),19-23。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 24. | Loboz-Grudzien, K.、Jaroch, J.(2011)。Women with acute coronary syndromes have a worse prognosis - why? The need to reduce 'treatment-seeking delay'。Cardiol J.,18,219-221。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 25. | Argulian, E.、Patel, A. D.、Abramson, J. L.(2006)。Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions。Am J Cardiol,98,48-53。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 26. | Ndrepepa, G.、Schulz, S.、Neumann, F. J.(2013)。Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy。Am Heart J,166,534-540。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 27. | Akhter, N.、Milford-Beland, S.、Roe, M. T.、Piana, R. N.、Kao, J.、Shroff, A.(2009)。Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)。Am Heart J.,157,141-148。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 28. | Suessenbacher, A.、Doerler, J.、Alber, H.(2008)。Gender-related outcome following percutaneous coronary intervention for ST-elevation myocardial infarction: data from the Austrian acute PCI registry。EuroIntervention,4,271-276。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 29. | Hoebers, L. P.、Claessen, B. E.、Dangas, G. D.(2013)。Longterm clinical outcomes after percutaneous coronary intervention for chronic total occlusions in elderly patients (≥ 75 years): five-year outcomes from a 1,791 patient multi-national registry。Catheter Cardiovasc Interv,82,85-92。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 30. | Lee, M. G.、Jeong, M. H.、Lee, K. H.(2012)。Prognostic impact of diabetes mellitus and hypertension for mid-term outcome of patients with acute myocardial infarction who underwent percutaneous coronary intervention。J Cardiol,60,257-63。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 31. | Wang, J. Y.、Wang, C. Y.、Juang, S. Y.(2014)。Low socioeconomic status increases short-term mortality of acute myocardial infarction despite universal health coverage。Int J Cardiol,172,82-87。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 32. | Khattab, A. A.、Hamm, C. W.、Senges, J.(2009)。Sirolimuseluting stent treatment at high-volume centers confers lower mortality at 6-month follow-up: results from the prospective multicenter German Cypher Registry。Circulation,120,600-606。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 33. | Shavers, V. L.(2007)。Measurement of socioeconomic status in health disparities research。J Natl Med Assoc,99(9),1013-1023。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 34. | McMurray, J. J.、Ostergren, J.、Swedberg, K.(2003)。Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial。Lancet,362,761-771。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 35. | Sanchis, J.、Nunez, J.、Bodi, V.(2011)。Influence of comorbid conditions on one-year outcomes in non-ST-segment elevation acute coronary syndrome。Mayo Clin Proc,86,291-296。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 36. | Romano, P. S.、Roos, L. L.、Jollis, J. G.(1993)。Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives。J. Clin. Epidemiol.,46,1075-1079。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 會議論文1. | Parng, I. M.、Chen, L. S.、Lee, C. H.、Chou, Y. J.(2008)。Impact of drug-eluting stents balance billing on recipients and treatment outcome。San Diego, CA:APHA。 ![](/gs32/thssjcncl/image/nclsfx.gif) ![new window](/gs32/images/newin.png) | 研究報告1. | 行政院衛生福利部統計處。死因統計。 延伸查詢![new window](/gs32/images/newin.png) | 學位論文1. | 葉憲宗(2010)。第二型糖尿病人施行塗藥血管支架手術後服用Thiazolidinediones對其預後之影響(碩士論文)。國立陽明大學,臺北。 延伸查詢![new window](/gs32/images/newin.png) | 2. | 郭淑惠(2008)。塗藥型血管支架納入健保部份給付之成效評估(碩士論文)。高雄醫學大學。 延伸查詢![new window](/gs32/images/newin.png) | 3. | 侯美夙(2008)。全國施行冠狀動脈繞道術及冠狀動脈介入性治療 之醫療品質與資源利用探討(碩士論文)。高雄醫學大學。 延伸查詢![new window](/gs32/images/newin.png) | 4. | 李佳俞(2009)。民眾對塗藥支架差額負擔的接受度--以台中某區域級教學醫院為例(碩士論文)。亞洲大學。 延伸查詢![new window](/gs32/images/newin.png) | 5. | 陳姿菁(2014)。接受塗藥心臟血管支架(DES)與傳統心臟血管支架(BMS)之病患其臨床結果及健保醫療資源利用分析(碩士論文)。國立陽明大學。 延伸查詢![new window](/gs32/images/newin.png) | 6. | 蘇美如(2012)。探討合併慢性腎臟病與使用塗藥支架對血管支架置入病人預後情形之影響(碩士論文)。國立陽明大學。 延伸查詢![new window](/gs32/images/newin.png) | 7. | 張煜詩(2013)。探討個人與區域社經地位對術後品質之影響-以冠狀動脈繞道手術病患為例(碩士論文)。國立陽明大學。 延伸查詢![new window](/gs32/images/newin.png) | 其他1. | 劉世奇(2013)。醫師說:「血管慢性阻塞太久,心導管很難打...」,我該怎麼辦?,http://www.skh.org.tw/download/血管慢性阻塞太久,%20心導管很難打通該怎麼辦.pdf, 2013/09/05。 延伸查詢![new window](/gs32/images/newin.png) | 2. | 台灣大學附設醫學院雲林分院心導管室(2013)。健保部份給付塗藥/塗層血管支架品項表,http://www.ylh.ntuh.gov.tw/upload/data/medicine_manage_training/2013_09_3_455257.pdf。 延伸查詢![new window](/gs32/images/newin.png) | |
| |